The CRAFFT is a (updated version of a) behavioral health screening tool for use with children ages and is recommended by the American Academy of . The CRAFFT Screening Interview. The CRAFFT is a behavioral health screening tool for use with children under the age of 21 and is recommended by the. CRAFFT is a screening tool for adolescent substance use that has been validated in outpatient general medical settings. This is the first study to examine its use.

Author: Kagam Kegis
Country: Algeria
Language: English (Spanish)
Genre: Sex
Published (Last): 20 October 2012
Pages: 432
PDF File Size: 11.69 Mb
ePub File Size: 10.40 Mb
ISBN: 622-1-84835-885-5
Downloads: 42211
Price: Free* [*Free Regsitration Required]
Uploader: Gakinos

Retrieved from ” https: The findings on prevalence may be further limited, in that the study sample, although generally reflective of the clinic population at large, was not selected randomly.

Substance abuse affects men and women of all screeninh, ethnic groups, and ages—including adolescents. To be practical, they must be designed to be completed by patients within the usual waiting time, and scoring procedures must be sufficiently streamlined so that results can be given to the physician before the medical visit begins.

One study reported that adolescent medical patients were frequently dishonest when answering providers’ questions about substance use because parents were present.

In clinic settings such as ours, one fourth of patients need at least a brief intervention, and one sixth likely need referral to a treatment specialist. National Survey Results on Drug Use, Future craffh on prevalence should address these limitations and include a larger and more diverse group of clinic settings.

Diagnostic classifications for substance use during the past 12 months were no use Guidelines for universal screening of adolescent patients screeninng substance use have been available for some time.

Adolescent alcohol and drug use and health. Guidelines cfafft Use in Primary Health Care. Adolescent use of alcohol and illicit substances is quite common among pediatric psychiatry inpatients; however, little data exist on substance use screening instruments that can be used to augment rcafft psychiatric diagnostic interviews.

New approaches, such as office-based interventions, must be developed to adequately meet the need for treatment. To assess the ability of the CRAFFT test to discriminate among diagnostic classification groups, we first converted CRAFFT scores to ranks, then used 1-way analysis of variance and a post-hoc comparison test to compare mean ranks between pairs of groups.


We excluded a total of 41 patients 5. Neuropsychiatric Disease and Treatment. Some providers may therefore choose to further assess those adolescents whose score is only 1.

CRAFFT as a Substance Use Screening Instrument for Adolescent Psychiatry Admissions.

However, we cannot assess to what degree they followed this instruction; provider selection bias, resulting in higher than actual prevalence estimates for disorders, remains a possibility. Although written questionnaires may crafrt an advantage in efficiency when patients complete them in the waiting area, they are limited by risks to confidentiality.

Corresponding author and reprints: Research has shown that CRAFFT has relatively high sensitivity and specificityinternal consistencyand test-retest reliability as a screener for alcohol and substance misuse. Although important, this risk is not necessarily related to having an alcohol- or drug-related disorder.

Providers can therefore determine the optimal score cut crafgt for the screening category they most wish to target and how best to interpret a positive screen in their own patient populations. Questionnaires may be targeted at substance use alone or include this as just one part of a more comprehensive adolescent screening.

Due to heteroscedasticity, we used the Tamhane T2 post hoc comparison test based on a t test that did not assume equal variance. The CRAFFT test has acceptable sensitivity and specificity for identifying all screening categories crxfft among crwfft demographic subgroups. Simple yes or no questions that lend themselves to mnemonic acronyms are ideal.

CRAFFT Screening Tool | Patient Centered Primary Care Institute

They may also pose a risk to adolescents’ confidentiality, especially when parents are present in the waiting area. First, the CRAFFT is the only screening test that includes an item on drinking and driving or riding with an intoxicated driver.

If universal screening is to improve, screeinng care systems must find ways to provide the additional resources needed for assessment of substance-using adolescents. Drug use is highly prevalent among adolescents, 2 and most providers would likely prefer a single test that can screen for all psychoactive substances simultaneously.

Despite these limitations, this study provides strong supportive evidence for the criterion validity of the CRAFFT test.

Validity of the CRAFFT Substance Abuse Screening Test Among Adolescent Clinic Patients

This study provides good supportive evidence for the validity of the CRAFFT test as a substance abuse screening device for use among a general population of adolescent clinic patients. All research assistants read the ADI manual, sccreening model interviews, screehing on volunteers, and were videotaped conducting practice interviews.


Subst Abus 37 ed. The sensitivity and specificity 0. This revised version of the CRAFFT screening tool incorporates changes that enhance the sensitivity of the system in terms of identifying adolescents with substance use, and presents new recommended clinician talking points, informed by the latest science and clinician feedback, to guide a brief discussion about substance use with adolescents.

The Nation’s Number 1 Health Problem. We transformed participant age into a dichotomous variable ie, younger youth and older youth based on craffr sample median to preserve adequate cell size for analyses.

Alcohol-associated motor vehicle accidents are a leading cause of death among adolescents, 38 and a question regarding this risk should be a part of routine screening. This is the first study to examine its use in adolescent psychiatric inpatients. Its name is a mnemonic of the first letters of key words in the test’s 6 questions. CRAFFT is a screening tool for adolescent substance use that has been validated in outpatient general medical settings.

This page was last edited on 3 Octoberat Therefore, its discriminant properties can help clinicians estimate not only the presence but also the magnitude of risk of substance-related problems. A research assistant explained the study procedures to interested patients and obtained signed assent.

CRAFFT as a Substance Use Screening Instrument for Adolescent Psychiatry Admissions.

Sign in to download free article PDFs Sign in to access your subscriptions Sign in to your personal account. A pilot study among adolescent patients who had used alcohol and other drugs found that CRAFFT had promising concurrent validity compared with a more lengthy scale. We performed a chart review of records from adolescents admitted to our inpatient psychiatric unit who completed a CRAFFT screen on admission.

Geneva, Switzerland World Health Organization. Arch Pediatr Adolesc Med. Of the 43 drug abuse diagnoses, 36 were related to cannabis, 5 to stimulants including caffeine pills, methylphenidate hydrochloride, and amphetaminesand 2 to both cannabis and stimulants. This study was conducted in a single urban hospital-based adolescent clinic.